| For: | Kwon Y, Kim ES, Choe YH, Kim MJ. How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study. World J Gastroenterol 2022; 28(28): 3666-3681 [PMID: 36161040 DOI: 10.3748/wjg.v28.i28.3666] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v28/i28/3666.htm |
| Number | Citing Articles |
| 1 |
Yiyoung Kwon, Yoon Zi Kim, Tae Jong Jeong, Seon Young Kim, Hansol Kim, Eun Sil Kim, Yon Ho Choe, Mi Jin Kim. Toward personalized therapeutic drug monitoring of ustekinumab in Crohn’s disease: influence of previous exposure to biologics. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848251393074
|
| 2 |
Rintaro Moroi, Yoichi Kakuta, Taku Obara, Yusuke Shimoyama, Takeo Naito, Hisashi Shiga, Yoshitaka Kinouchi, Atsushi Masamune. Long‐term prognosis and clinical practice for new‐onset ulcerative colitis in the era of biologics: A Japanese retrospective study. JGH Open 2023; 7(10): 682 doi: 10.1002/jgh3.12957
|
